These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15702203)

  • 1. Some problems with the investigation of noninferiority in meta-analysis.
    Witte S; Victor N
    Methods Inf Med; 2004; 43(5):470-4. PubMed ID: 15702203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials.
    Baujat B; Mahé C; Pignon JP; Hill C
    Stat Med; 2002 Sep; 21(18):2641-52. PubMed ID: 12228882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive and repeated cumulative meta-analyses of safety data during a new drug development process.
    Quan H; Ma Y; Zheng Y; Cho M; Lorenzato C; Hecquet C
    Pharm Stat; 2015; 14(3):161-71. PubMed ID: 25612310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should meta-regression analyses be undertaken and interpreted?
    Thompson SG; Higgins JP
    Stat Med; 2002 Jun; 21(11):1559-73. PubMed ID: 12111920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis: methods, strengths, and weaknesses.
    Buyse M; Piedbois P; Piedbois Y; Carlson RW
    Oncology (Williston Park); 2000 Mar; 14(3):437-43; discussion 444, 447. PubMed ID: 10742969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM; Wang SJ; O'Neill R
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quo vadis meta-analysis? A potentially dangerous tool if used without adequate rules.
    Michels KB
    Important Adv Oncol; 1992; ():243-8. PubMed ID: 1582676
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis, Simpson's paradox, and the number needed to treat.
    Altman DG; Deeks JJ
    BMC Med Res Methodol; 2002; 2():3. PubMed ID: 11860606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five easy pieces on evidence-based medicine (4).
    Kalso E; Edwards J; McQuay HJ; Moore RA
    Eur J Pain; 2002; 6(1):89-93. PubMed ID: 11888232
    [No Abstract]   [Full Text] [Related]  

  • 10. Meta-analysis: weighing the evidence.
    Jones DR
    Stat Med; 1995 Jan; 14(2):137-49. PubMed ID: 7754262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The meta-analysis of clinical studies: the philosopher's stone or a bone of contention?].
    Baumann M
    Strahlenther Onkol; 1999 Apr; 175 Suppl 1():17-20. PubMed ID: 10230453
    [No Abstract]   [Full Text] [Related]  

  • 12. Exploring heterogeneity in meta-analyses: needs, resources and challenges.
    Xu H; Platt RW; Luo ZC; Wei S; Fraser WD
    Paediatr Perinat Epidemiol; 2008 Jan; 22 Suppl 1():18-28. PubMed ID: 18237348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomization as a basis for inference in noninferiority trials.
    Wiens BL
    Pharm Stat; 2006; 5(4):265-71. PubMed ID: 17128425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carry-over.
    Curtin F; Elbourne D; Altman DG
    Stat Med; 2002 Aug; 21(15):2161-73. PubMed ID: 12210631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced methods in meta-analysis: multivariate approach and meta-regression.
    van Houwelingen HC; Arends LR; Stijnen T
    Stat Med; 2002 Feb; 21(4):589-624. PubMed ID: 11836738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y; Zhang J; Levenson M
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good enough: a primer on the analysis and interpretation of noninferiority trials.
    Kaul S; Diamond GA
    Ann Intern Med; 2006 Jul; 145(1):62-9. PubMed ID: 16818930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analysis as a tool for gaining knowledge].
    Koch A; Ziegler S
    Med Klin (Munich); 2000 May; 95(1 Spec No):83-90. PubMed ID: 10851854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias in meta-analysis and funnel plot asymmetry.
    Biljana M; Jelena M; Branislav J; Milorad R
    Stud Health Technol Inform; 1999; 68():323-8. PubMed ID: 10724898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.